| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 164812* | 2009 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 136780 | 2009 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 136102 | 2009 |
| Statistical methods for assessing agreement between two methods of clinical measurement JM Bland, DG Altman The lancet 327 (8476), 307-310, 1986 | 56479 | 1986 |
| Statistical methods for assessing agreement between two methods of clinical measurements JM Blaud, DG Altman Lancet 12, 307-310, 1986 | 56442 | 1986 |
| Measuring inconsistency in meta-analyses JPT Higgins, SG Thompson, JJ Deeks, DG Altman Bmj 327 (7414), 557-560, 2003 | 53141 | 2003 |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ... Annals of internal medicine 151 (4), W-65-W-94, 2009 | 50066 | 2009 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... The lancet 370 (9596), 1453-1457, 2007 | 46753* | 2007 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... The lancet 370 (9596), 1453-1457, 2007 | 46744* | 2007 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... The lancet 370 (9596), 1453-1457, 2007 | 46616* | 2007 |
| The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JPT Higgins, DG Altman, PC Gøtzsche, P Jüni, D Moher, AD Oxman, ... Bmj 343, 2011 | 28384 | 2011 |
| Practical statistics for medical research DG Altman Chapman and Hall/CRC, 1990 | 25702 | 1990 |
| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 16962 | 2017 |
| QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies PF Whiting, AWS Rutjes, ME Westwood, S Mallett, JJ Deeks, JB Reitsma, ... Annals of internal medicine 155 (8), 529-536, 2011 | 11349 | 2011 |
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... bmj 355, 2016 | 11204 | 2016 |
| Measuring agreement in method comparison studies JM Bland, DG Altman Statistical methods in medical research 8 (2), 135-160, 1999 | 10089 | 1999 |
| Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ... Annals of internal medicine 147 (8), W-163-W-194, 2007 | 9847 | 2007 |
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials D Moher, KF Schulz, DG Altman The lancet 357 (9263), 1191-1194, 2001 | 9838 | 2001 |
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials D Moher, KF Schulz, DG Altman The lancet 357 (9263), 1191-1194, 2001 | 9687 | 2001 |
| Assessing risk of bias in included studies JPT Higgins, DG Altman Cochrane handbook for systematic reviews of interventions: Cochrane book …, 2008 | 8618* | 2008 |
